ONC213 asserts its effectiveness on AML cells through targeting oxidative phosphorylation via inhibition of α-KGDH which subsequently induces mitochondrial stress pathways (p-eIF2-α) and reduces levels of Mcl-1. This evidence concerns the gene EIF2A and acute myeloid leukemia.